ak 2123 has been researched along with lutetium in 1 studies
| Studies (ak 2123) | Trials (ak 2123) | Recent Studies (post-2010) (ak 2123) | Studies (lutetium) | Trials (lutetium) | Recent Studies (post-2010) (lutetium) |
|---|---|---|---|---|---|
| 52 | 8 | 5 | 1,192 | 44 | 844 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, S; Chakraborty, S; Das, T; Kagiya, VT; Mukherjee, A; Nair, CK; Samuel, G; Sarma, HD; Venkatesh, M | 1 |
1 other study(ies) available for ak 2123 and lutetium
| Article | Year |
|---|---|
Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia.
Topics: Animals; Antineoplastic Agents; Drug Delivery Systems; Fibrosarcoma; Hypoxia; Lutetium; Mice; Neoplasms; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Triazoles | 2004 |